Skip to main content

WeRide and Renault Group Return to Roland-Garros for Third Straight Year with Autonomous Robobus Service

PARIS, May 26, 2026 (GLOBE NEWSWIRE) — WeRide (NASDAQ: WRD, HKEX: 0800), a global leader in autonomous driving technology, today announced that it will once again deploy its autonomous Robobus at the Roland-Garros tournament – marking the third consecutive year of operations in partnership with Renault Group. Since 2024, the WeRide Robobus has provided the only autonomous public shuttle service at Roland-Garros, showcasing next-generation autonomous driving technology at one of the world’s most prestigious sporting events.WeRide Robobus at Roland-Garros Held annually in Paris, Roland-Garros – also known as the French Open – is one of the four Grand Slam tennis tournaments, drawing top-ranked players and hundreds of thousands of spectators each year. Its high‑density, high‑demand transport environment offers a real‑world...

Continue reading

CBAK Energy Powers Southeast Asia’s Electric Mobility with Innovative LFP Cylindrical Batteries

HO CHI MINH CITY, Vietnam, May 26, 2026 (GLOBE NEWSWIRE) — CBAK Energy Technology, Inc. (NASDAQ: CBAT) (“CBAK Energy”, or the “Company”), a leading lithium-ion battery manufacturer and electric energy solution provider in China, highlights its scenario-driven Light Electric Vehicles (LEVs) product lineup for Southeast Asia’s rapidly growing electric mobility sector at the 22nd International Exhibition on Automobile, Motorcycle, Electric Vehicle and Supporting Industries (Autotech & Accessories 2026). Engineered for Southeast Asia’s demanding E2W/E3W market, the comprehensive portfolio features the company’s flagship Full-Tab Large Cylindrical cells (including the 32140 and 40135 series), pioneering Sodium-Ion batteries (32140), and the specialized 26 series (26650/26700) built for high-rate, high-safety, and extreme temperature...

Continue reading

Share Buy-back Programme – Transactions Week 21

On 12 May 2026, Gabriel Holding A/S initiated a share buy-back programme. The buy-back runs from 12 May 2026 up to and including 16 March 2027. During this period, Gabriel Holding A/S may repurchase up to 94,500 shares corresponding to 5% of the share capital. Gabriel Holding A/S held 55,109 treasury shares at the start of the share buyback programme. The buy-back is executed in accordance with Article 5 of Regulation (EU) No. 596/2014 of the European Parliament and of the Council of 16 April 2014 (MAR) and Commission Delegated Regulation (EU) 2016/1052, also referred to as the Safe Harbour Regulation. The buy-back is carried out on Nasdaq Copenhagen at market price and in accordance with the authorization granted by the general meeting, Nasdaq Copenhagen’s rules for issuers, as well as Gabriel Holding A/S’ internal rules on insider matters...

Continue reading

ONWARD Medical Reports First Quarter 2026 Results with Strong Commercial Momentum and Key Clinical Milestones

EINDHOVEN, the Netherlands, May 26, 2026 (GLOBE NEWSWIRE) — ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and independence in people with spinal cord injuries (SCI) and other movement disabilities, today announced its results for the first quarter of 2026:Commercial traction: The Company supplied 70 ARC-EX® Systems for use in clinics and homes. ARC-EX was available in more than 100 clinics across the US and Europe by the end of the first quarter. Clinical milestones: The Company announced additional implants across its ARC-IM® and ARC-BCI® platforms, including the first participant enrollment and first successful implant in the Empower BP global pivotal study. Financial highlights: The Company reported EUR 2.0 million in revenue in...

Continue reading

TCM Group A/S: Change in executive management – TCM Group appoints new CFO.

COMPANY ANNOUNCEMENT No. 268/2026 Tvis, 26 May 2026 Change in executive management – TCM Group appoints new CFO. TCM Group appoints Esben Refsgaard Trier Lund as CFO with start date no later than November 1, 2026. CEO Torben Paulin:“I am pleased to announce that TCM Group has appointed Esben Refsgaard Trier Lund as Chief Financial Officer (CFO), with start date no later than November 1, 2026. Esben brings extensive experience from CFO positions in international manufacturing companies, most recently serving as Group CFO at Vald. Birn A/S, one of the largest foundry groups in Northern Europe. Esben also has significant experience with M&A processes and subsequent business and organizational structuring. TCM Group looks forward to welcoming Esben and benefiting from his deep knowledge of manufacturing companies and international...

Continue reading

Activity results of AB Kauno energija of the 1 quarter of the year 2026

The Management Board of AB Kauno Energija (hereinafter – the Company) (code – 235014830) assessed the results of Company’s business activity of the 1 quarter of the year 2026 and financial state as at March 31, 2026 and approved on May 25, 2026 AB Kauno Energija consolidated and Company’s non-audited results of the 1 quarter of the year 2026. The result of Company’s business activities of the 1 quarter of the year 2026 according to the International Financial Reporting Standards is profit in amount of EUR 16,331 thousand (the profit of the 1 quarter of the year 2025 was EUR 13,822 thousand), turnover from sales is EUR 61,879 thousand (in the 1 quarter of the year 2025 it was EUR 43,301 thousand). The profit of the Group which consists of AB Kauno Energija and its’ subsidiaries UAB GO Energy LT (code – 303042623), amounts to EUR 16,425...

Continue reading

New Novartis data at ERA 2026 advance scientific understanding of kidney disease and reinforce portfolio strength

Late-breaking Phase III IgAN data for Vanrafia ALIGN and Fabhalta APPLAUSE-IgAN studies to be presented 124-week Phase I/II zigakibart data evaluating treatment efficacy and safety in IgAN will be featured New insights into disease characteristics in IgAN and C3G inform future research and treatment approachesBasel, May 26, 2026 – Novartis will present data from 15 abstracts from its kidney portfolio at this year’s European Renal Association (ERA) Congress in Glasgow, June 3-6. The presentations reinforce our ambition to advance scientific understanding across progressive immune-mediated kidney diseases and support the evolution of kidney care. Presentations include late-breaking Phase III results for Vanrafia® (atrasentan) and Fabhalta® (iptacopan), along with extended follow-up data from the investigational anti-APRIL therapy zigakibart...

Continue reading

Share repurchase programme: Transactions of week 21 2026

The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The following transactions have been made under the program:  Number of shares Average purchase price (DKK) Transaction value (DKK)Accumulated, previous announcement 992,622 904.24 897,569,60918 May 2026 12,500 888.33 11,104,08819 May 2026 16,745 898.87 15,051,63320 May 2026 12,903 899.71 11,608,91221...

Continue reading

High Arctic Overseas Announces Intention to Recommence Drilling Activity in Papua New Guinea

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAW CALGARY, Alberta, May 25, 2026 (GLOBE NEWSWIRE) — High Arctic Overseas Holdings Corp. (TSXV: HOH) (“High Arctic Overseas” or the “Corporation”) is pleased to announce that today it received notice from its principal drilling customer to recommence drilling services in Papua New Guinea (“PNG”). The notice received today follows the announcement on April 30, 2026 of the renewal of the long-standing drilling services contract between High Arctic and it’s principal customer in PNG. The notice calls for the remobilisation of personnel and equipment commencing in July 2026, for the reactivation of Drilling Rig 103. The two year renewal of the drilling services...

Continue reading

Rapid Nutrition Completes A$2 Million Australian Wellness Platform Transaction

LONDON, May 25, 2026 (GLOBE NEWSWIRE) — Rapid Nutrition PLC (Euronext Growth: ALRPD), a global HealthTech company focused on evidence-based nutrition brands, today provides an update on the Australian wellness platform transaction first announced on 23 April 2026 and most recently updated on 19 May 2026, with settlement scheduled prior to the end of H1 2026. Aggregate consideration of approximately A$2 million was funded entirely from existing cash resources, together with a performance-based earn-out payable subject to agreed operational conditions approximately 12 months following completion. The transaction was structured without any equity issuance and therefore involves no shareholder dilution. The acquired platform operates as the Group’s Australian flagship and provides access to a portfolio of more than 89 leading...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.